You asked if this is
outbound for AccessSync.
Growth here still clusters around show season.
You wrote it about access. It is true of pipeline too.
Build. Run. Own.
Build
We design, staff and stand up the complete unit. The named-account data, the messaging, the outbound engine, the automation and the reporting.
Run
We run it in market for a fixed four months and prove it on real booked meetings, not slides. First conversations land early.
Own
We hand over the playbook, the tooling, the dashboards and a trained operator. You own the engine.
Three things, built for market access.
Named-account targeting
The market access, field reimbursement and brand leaders at the biopharma organizations worth opening, built into a working list you can argue with.
Messages to one person
Every message written for one named contact, off their brand, their therapeutic area and what they have said publicly. No blasts and no templates.
A warm handoff
A positive reply reaches you and your operator with the person and a way to reach them, so you pick it up while it is warm.
Every message, written for one real person.
Target
We build the list of market access, reimbursement and brand leaders at the biopharma organizations worth opening.
Personalize
AI reads each profile and writes a unique message. No templates.
Hand off warm
A positive reply pings you and your operator with the prospect and a way to reach them.
You take it from there
You take pre-qualified conversations. The engine handles everything before it.
Built to hand over, not to rent forever.
You own it at the end
We design it, staff it and run it for four months, then hand over the playbook, the tooling and a trained operator. No permanent retainer.
It suits a named market
Market access leaders are a defined, nameable population. That rewards precision over volume, which is exactly what this engine is built for.
It runs between the shows
Asembia is one week. This runs the other fifty one, on the same accounts you want to meet there.
Numbers from live campaigns, not projections.
Enquirer AI helps us identify the right people and start the conversation in a much smarter way.
You own it at the end. That is the difference.
Stand up fast. Prove it. Then scale.
Build
The named-account data, the messaging, the engine and the dashboard. Day-one capacity from warmed assets and managed seats.
The test
Run against the KPIs we agree up front. First meetings on the calendar early.
Ramp
Once the numbers hold, ramp the seats and breadth to the volume you want.
Hand over
Playbook, tooling, dashboards and a trained operator. The engine is yours.
Let's see if the mechanism fits.
- A short call with Matthew, 20 minutes, at a time that suits you. He answers the rest of the question you asked.
- He brings the named biopharma accounts and the exact market access leaders we would start with. You tell us if the list is right.
- If it fits, we agree the scope and a start date. If not, you keep the read.